NOVONIX Ltd Files Form 6-K for December 2024
Ticker: NVNXF · Form: 6-K · Filed: Dec 17, 2024 · CIK: 1859795
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, sec-filing
Related Tickers: NVX
TL;DR
NOVONIX filed a routine 6-K, confirming 20-F reporting. No new financials.
AI Summary
NOVONIX Limited filed a Form 6-K on December 17, 2024, reporting for the month of December 2024. The filing indicates that NOVONIX is a foreign private issuer and will file its annual reports under Form 20-F. The document primarily serves as a notification and does not contain specific financial figures or operational updates within the provided text.
Why It Matters
This filing confirms NOVONIX's status as a foreign private issuer and its reporting schedule, which is important for investors tracking its regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a standard regulatory report and does not contain new material financial or operational information that would typically impact risk.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
- December 2024 (date) — Reporting period
- December 17, 2024 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of December 2024.
Which annual report form does NOVONIX Limited file?
NOVONIX Limited files its annual reports under cover of Form 20-F.
What is the Commission File Number for NOVONIX Limited?
The Commission File Number for NOVONIX Limited is 001-41208.
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Does this filing contain specific financial results for December 2024?
The provided text of the Form 6-K does not contain specific financial results; it primarily serves as a notification and lists exhibits.
Filing Stats: 195 words · 1 min read · ~1 pages · Grade level 13 · Accepted 2024-12-17 09:00:03
Filing Documents
- nvx-6k-dec-24-12-17_lpoa.htm (6-K) — 18KB
- nvx-ex99_1.htm (EX-99.1) — 40KB
- img58969013_0.jpg (GRAPHIC) — 5KB
- img58969013_1.jpg (GRAPHIC) — 69KB
- 0000950170-24-136923.txt ( ) — 162KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: December 17, 2024